DeutschPaediatric Rheumatology
Prof. Dr. med. Kirsten MindenPaediatric Rheumatology
Prof. Dr. med. Kirsten Minden
Scientific career and Key Publications
Kirsten Minden is a paediatric rheumatologist and professor for health services research in rheumatology at the Charité – Universitätsmedizin Berlin, Department of Pediatrics, Respiratory Medicine, Immunology and Critical Care Medicine, and at the German Rheumatism Research Centre (DRFZ).
She trained in Paediatrics and Paediatric Rheumatology at the 2nd Children’s hospital in Berlin-Buch (later: Helios-Klinikum Berlin-Buch). Since 2006, she has been working at the Children’s university hospital of the Charité.
Her areas of interest include childhood arthritis (juvenile idiopathic arthritis, JIA) and other juvenile rheumatic diseases. She has a regular clinic in the Centre for Chronically Sick Children at the Charité Camus Virchow where she sees children and adolescents with arthritis and other rheumatic conditions.
At the DRFZ, she runs a research group that investigates phenotypes, courses, and outcomes of juvenile rheumatic diseases as well as the health care situation of children and young people with rheumatic diseases.
She is the principal investigator of the national paediatric rheumatologic database, the inception cohort of newly diagnosed children with JIA (ICON) and the JIA biologic registry JuMBO.
Kirsten Minden is author/co-author of over 150 pub-med listed publications and a member of several scientific organisations, e.g., the Society for Paediatric Rheumatology (GKJR), the German Society for Rheumatology (DGRh), the German Society for Paediatrics (DGKJ), the Deutsche Rheumaliga, the Paediatric Rheumatology European Society (PReS), the Paediatric Rheumatology INternational Trials Organisation (PRINTO), the German Society for Transitional Medicine (DGfTM). She is, among other activities, the spokesperson of the commission “Health Care and Quality Assurance” of the GKJR and the working group “Transition” of the DGRh and GKJR.
| Seit 2015 | Professorin für Versorgungsforschung in der Rheumatologie an der Charité Universitätsmedizin Berlin und am Deutschen Rheuma-Forschungszentrum Berlin |
| 2012 | Habilitation |
| Seit 2001 | Wissenschaftlerin am DRFZ, Programmbereich Epidemiologie, seit 2009 Leiterin der Arbeitsgruppe Kinderrheumatologie und Versorgungsforschung |
| Seit 2006 | Kinderrheumatologin im Sozialpädiatrischen Zentrum des Charité Centrums 17 für Frauen-, Kinder- und Jugendmedizin mit Perinatalzentrum und Humangenetik |
| 2003-2006 | Oberärztin der Abteilung Kinder- und Jugendrheumatologie des Helios-Klinikums Berlin-Buch |
| 1997-2003 | Fachärztin in der Abteilung Kinderrheumatologie des HELIOS-Klinikums Berlin-Buch |
| 1992-1996 | Assistenzärztin in der II. Klinik für Kinderheilkunde und Jugendmedizin des Klinikums Berlin-Buch |
| 1990-1992 | Ärztin im Praktikum in der II. Klinik für Kinderheilkunde und Jugendmedizin des Klinikums Berlin-Buch |
| 1989 | Promotion (Klinik für Orthopädie, Charité Universitätsmedizin Berlin) |
| 1985 | Diplom der Medizin (Institut für Anatomie, Charité Universitätsmedizin Berlin) |
| 2006 | Additional qualification paediatric rheumatology |
| 2001 | Intensive Course in Applied Epidemiology, ARC Epidemiology, University of Manchester, Great Britain |
| 1996 | Specialist for paediatrics and adolescent medicine |
| 1992 | Approbation |
| 1982-1990 | Study of human medicine; Charité University Medicine Berlin |
| Since 2017 | Board member of the Initiative für das rheumakranke Kind |
| Since 2015 | Member of the scientific advisory board of the Journal of Rheumatology |
| Since 2014 | Speaker of the working group Transition of the Society for Pediatric Rheumatology |
| Since 2011 | Member of the scientific advisory board of the Journal arthritis+rheuma, from 2011-2019 head of the section paediatric rheumatology |
| Since 2005 | Speaker of the Commission Care and Quality Assurance of the Society for Pediatric Rheumatology |
| 2004-2017 | Board member of the Society for Pediatric Rheumatology |
• German Network for Healthcare Research (DNVF
• German Society for Rheumatology (DGRh)
• German Society for Pediatric Rheumatology (GKJR)
• Paediatric Rheumatology European Society (PReS)
• German Society for Pediatric and Adolescent Medicine (DGKJ)
• Deutsche Rheuma-Liga
| 2013, 2015 | Pfizer Research Prize for Rheumatology |
| 2017 | Transition Prize of the Society for Transition Medicine |
Drechsel P, Stüdemann K, Niewerth M, Horneff G, Fischer-Betz R, Seipelt E, Spähtling-Mestekemper S, Aries P, Zink A, Klotsche J, Minden K. Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis – Results from a JIA Biologic Registry. Rheumatology (Oxford). Rheumatology (Oxford). 2020 Mar 1;59(3):603-612.
Minden K, Horneff G, Niewerth M, Seipelt E, Aringer M, Aries P, Foeldvari I, Haas JP, Klein A, Tatsis S, Tenbrock K, Zink A, Klotsche J. The time of DMARD start in Juvenile Idiopathic Arthritis determines the likelihood of a drug-free remission in young adulthood. Arthritis Care Res (Hoboken). 2019 Apr;71(4):471-481.
Foster HE*, Minden K*, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Dermikaya E, Ozen S, Carmona L. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017 Apr;76(4):639-646 (*contributed equally).
Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). Ann Rheum Dis. 2016;75:855-61.
Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K; German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007;46:1015-9.
Minden K, Niewerth M, Listing J, Biedermann T, Schöntube M, Zink A. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2004;63;836-42.
Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, Zink A. Long-term outcome in patients with juvenile idiopathic arthritis Arthritis Rheum 2002;46:2392-401.